July 16, 2018. The Lupus Research Alliance is pleased and very encouraged to share a promising scientific breakthrough reported in the New York Times with real potential to revolutionize lupus treatment. Just reported in the prestigious journal Nature, scientists in Dr. Alexander Marson’s lab at the University of California, San Francisco have developed an innovative […] READ MORE
2018 Lupus Insight Prize Presented to Dr. Betty Diamond Funds Study of Common Hypertension Drugs to Treat Lupus June 21, 2018 The Lupus Research Alliance has awarded its 2018 Lupus Insight Prize to Betty Diamond, MD, for a project to test commonly used drugs for high blood pressure as potential treatments for cognitive and emotional […] READ MORE
2018 Handbag Luncheon Honors PUMA for Selena Gomez Lupus Campaign NEW YORK, NY – May 22, 2018. The 9th annual Lupus Research Alliance Lupus Handbag Luncheon & Silent Auction honored two stand-out supporters to the lupus cause: world-leading sports brand PUMA and IBM Associate Partner Veronica Vargas Lupo. PUMA was named “Corporate Visionary Partner” in […] READ MORE
April 26, 2018 Lupus Research Alliance and Lupus Therapeutics collaborate with Bristol-Myers Squibb on a New Lupus Trial The Lupus Research Alliance today announced a collaboration between its newly formed affiliate, Lupus Therapeutics, and the pharmaceutical company, Bristol-Myers Squibb (BMS), to test a novel investigational drug, BMS-986165, as a potential new therapy for lupus. The […] READ MORE
March 23, 2018 The Omnibus Appropriations bill for Fiscal Year 2018 that passed today includes key provisions the Lupus Research Alliance and lupus advocates have worked for all year. Lupus advocates, participating just days before for our annual March Capitol Hill Day, had requested program funding for 2019 and had asked legislators to also finish […] READ MORE
February 21, 2018 Source: Press Release, National Institutes of Health NIH program to accelerate therapies for arthritis, lupus releases first datasets Collaborative effort provides important clues about potential research targets NEW YORK, NY. Feb. 21, 2018. Datasets characterizing individual cells in rheumatoid arthritis and systemic lupus erythematosus disease tissue from the Accelerating Medicines Partnership for […] READ MORE
Jan. 10, 2018 Lupus Research Alliance Announces New Grants for Translational Research Seven Outstanding Investigators Chosen for Prestigious Lupus Research Grants The Lupus Research Alliance is proud to announce the recipients of its Target Identification in Lupus (TIL) grants designed to move research discoveries quickly from the laboratory to the patient’s bedside. Seven outstanding scientists […] READ MORE
The Lupus Research Alliance and the National Minority Quality Forum Announce Lupus Multi-Cultural Engagement Partnership NEW YORK, December 19, 2017 — The Lupus Research Alliance and the National Minority Quality Forum launched the Lupus Multi-Cultural Engagement Partnership at the recent inaugural meeting in New York City which was attended by 30 national experts and key […] READ MORE
Lupus Research Alliance Welcomes Steve Burke, Selena Gomez, Seth Meyers and Kelli O’Hara to Breaking through Lupus Gala Raises Over $3.2 Million for Lupus Research November 21, 2017 – New York, NY – The Lupus Research Alliance celebrated the 2017 Breaking through Lupus Gala to shed a spotlight on breakthroughs from the previous years, and […] READ MORE
Two Outstanding Scientists Recognized for Transformative Lupus Research Projects Nov. 09, 2017. The Lupus Research Alliance is proud to announce the 2017 recipients of the Dr. William E. Paul Distinguished Innovator Awards in Lupus and Autoimmunity. Michael Carroll, PhD, Children’s Hospital Boston, is studying why and how lupus attacks the brain and central nervous system […] READ MORE
Lupus Research Alliance welcomes compelling new data, presented at the American College of Rheumatology (ACR) annual meeting that demonstrated significant benefit for lupus patients treated with Stelara® (ustekinumab), a prescription medicine from the Janssen Pharmaceutical Companies. Stelara® is not approved for the treatment of lupus, but is approved by the FDA for certain autoimmune diseases. Through its drug repurposing program, the Lupus Research Alliance first identified Stelara® as a potential treatment for lupus and encouraged Janssen to pursue testing for this use. READ MORE
NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN) aimed at discovering new treatments for the millions of people around the globe living with lupus. Recognizing the limited treatments for lupus, LuCIN was organized, managed and is […] READ MORE
